Pre-empting Antibody-Mediated Rejection: A Program of DSA Monitoring and Treatment Can Effectively Prevent Antibody Mediated Rejection.
In conclusion, a program of universal risk-stratified DSA testing in kidney transplant patients can dramatically reduce rates of AMR and virtually eliminate graft loss due to AMR.
PMID: 28564526 [PubMed - in process]
Source: Clinical Transplants - Category: Transplant Surgery Tags: Clin Transpl Source Type: research
More News: Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology